Treatment evaluation of genetic surfactant disorder with a high-flow nasal cannula.

Nogami, Masao; Wada, Soichiro; Sai, Shuji; Onda, Tetsuo; Cho, Kazutoshi

Nogami, Masao; Wada, Soichiro; Sai, Shuji; Onda, Tetsuo; Cho, Kazutoshi.

Affiliation

Nogami M; Department of Pediatrics, Teine Keijinkai Hospital, Sapporo, Japan.
Wada S; Department of Pediatrics, Teine Keijinkai Hospital, Sapporo, Japan.
Sai S; Department of Pediatrics, Teine Keijinkai Hospital, Sapporo, Japan.
Onda T; Maternity and Perinatal Care Center, Hokkaido University Hospital, Sapporo, Japan.
Cho K; Maternity and Perinatal Care Center, Hokkaido University Hospital, Sapporo, Japan.

Pediatr Int ; 64(1): e15004, 2022 Jan.

Article in En | MEDLINE | ID: mdl-35278247

Subject(s)

Cannula; Pulmonary Surfactants; Humans; Oxygen Inhalation Therapy; Pulmonary Surfactants/therapeutic use; Surface-Active Agents

Key words

hereditary interstitial lung disease; high-flow nasal cannula; hydroxychloroquine; surfactant protein C dysfunction

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Surfactants / Cannula Limits: Humans Language: En Journal: Pediatr Int Journal subject: PEDIATRIA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google